U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 16 results

Status:
US Approved Rx (2018)
First approved in 2002

Class (Stereo):
CHEMICAL (ACHIRAL)



The potential antiviral effect of adefovir, an acyclic nucleoside phosphonate analog of 2′-deoxyadenosine monophosphate, was first studied by Holý and De Clercq in 1980s. Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is ph...
Status:
US Approved Rx (1995)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)



Lamivudine is a reverse transcriptase inhibitor used alone or in combination with other classes of anti-human immunodeficiency virus (HIV) drugs in the treatment of HIV infection. This molecule has two stereo-centers, thus giving rise to four stereoi...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cinobufotalin, the bufadienolide isolated from toad venom, has displayed antitumor activities in many in vitro systems. It has been shown that cinobufotalin induced significant apoptosis in cultured human lymphoma U-937 cells. It induced DNA fragment...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)



Vesatolimod, also known as GS-9620, is being developed in clinical studies for the treatment of chronic hepatitis B viral (HBV) infection, with the goal of inducing a liver-targeted antiviral effect without inducing the adverse effects associated wi...
Status:
US Previously Marketed
First approved in 2006

Class (Stereo):
CHEMICAL (ABSOLUTE)

Targets:


Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (Europe) and Tyzeka (United States). Clinical trials have shown it to be significant...
Status:
Possibly Marketed Outside US
First approved in 2022

Class (Stereo):
CHEMICAL (ACHIRAL)



Propagermanium, a newly introduced hydrophilic polymer of 3-oxygermanium propionic acid (3,3’-(1,3- dioxo-1,3-digermoxanediyl) bispropionic acid) has been reported to have antiinflammatory, antiviral and antineoplastic properties. In Japan propagerma...
Status:
Possibly Marketed Outside US
First approved in 2018

Class (Stereo):
CHEMICAL (ABSOLUTE)



Matrine is an active alkaloid, extracted from a traditional Chinese herbs of the Sophora family. Matrine has been reported for its anti-inflammatory and neuroprotective effects. It was demonstrated that the antinociceptive effects of ( )-matrine was...
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (ABSOLUTE)



Clevudine (also known as L-FMAU) is a nucleos(t)ide reverse transcriptase inhibitor, which inhibits the DNA synthesis activity of the hepatitis B virus polymerase. The drug was approved in Korea and Philippines and is being marketed under the names L...
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (ABSOLUTE)



Oxymatrine is one of the key components extracted from Sophora flavescens, a leguminous plant grown in China, Japan, and some European countries. It has attracted much attention because of its low toxicity and side effects. Extensive research over t...
Status:
US Approved Rx (2018)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)



The potential antiviral effect of adefovir, an acyclic nucleoside phosphonate analog of 2′-deoxyadenosine monophosphate, was first studied by Holý and De Clercq in 1980s. Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is ph...

Showing 1 - 10 of 16 results